(Total Views: 509)
Posted On: 08/12/2022 7:49:13 PM
Post# of 145875
![Avatar](https://investorshangout.com/images/ProfileImages/no_avatar_available.jpg)
Re: HouseofCards #127565
Relax… our time will come… Look at Novavax and see what happened to them. I am sure we will see the same urgency that Novavax received.
Novavax submitted their phase 3 results to the FDA for review and seeking a EUA just 6 short months ago. How long did it take Pfizer?? Was it 2 or 3 days for approval? Over 6 months for Novavax.
Novavax has a top line trial that exceeds the other two vaccines with better results. So… what did the FDA do for them? Restrict them to a only a new patient only option in the USA? You can only get the Jab if you have never had either one of the others. Why? Because they wanted to protect big Pharma’s sales… that’s why.
It’s just like our HIV BLA… we can’t just open market our drug to compete on its own merit of being better. Leronlimab can only be used if two other Hart drugs have failed. Does this sound fair to Leronlimab? I don’t think so… but this is life in the drug world and it stinks to high heaven. Here we sit waiting months after months for a restart of our trials and a clinical lift based on what we know is a great safety record. What can we do? Just wait…
Novavax submitted their phase 3 results to the FDA for review and seeking a EUA just 6 short months ago. How long did it take Pfizer?? Was it 2 or 3 days for approval? Over 6 months for Novavax.
Novavax has a top line trial that exceeds the other two vaccines with better results. So… what did the FDA do for them? Restrict them to a only a new patient only option in the USA? You can only get the Jab if you have never had either one of the others. Why? Because they wanted to protect big Pharma’s sales… that’s why.
It’s just like our HIV BLA… we can’t just open market our drug to compete on its own merit of being better. Leronlimab can only be used if two other Hart drugs have failed. Does this sound fair to Leronlimab? I don’t think so… but this is life in the drug world and it stinks to high heaven. Here we sit waiting months after months for a restart of our trials and a clinical lift based on what we know is a great safety record. What can we do? Just wait…
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)